KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for BioNTech SE (BNTX) over the last 7 years, with Q3 2025 value amounting to 0.05%.

  • BioNTech SE's Return on Capital Employed changed 0.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.06% for FY2024, which is 1000.0% down from last year.
  • BioNTech SE's Return on Capital Employed amounted to 0.05% in Q3 2025, which was down 0.0% from 0.05% recorded in Q2 2025.
  • BioNTech SE's 5-year Return on Capital Employed high stood at 1.79% for Q2 2021, and its period low was 0.07% during Q1 2025.
  • Its 5-year average for Return on Capital Employed is 0.47%, with a median of 0.27% in 2023.
  • Per our database at Business Quant, BioNTech SE's Return on Capital Employed soared by 20500bps in 2021 and then crashed by -10700bps in 2022.
  • BioNTech SE's Return on Capital Employed (Quarter) stood at 0.94% in 2021, then decreased by -29bps to 0.66% in 2022, then crashed by -95bps to 0.03% in 2023, then plummeted by -299bps to 0.07% in 2024, then rose by 29bps to 0.05% in 2025.
  • Its Return on Capital Employed was 0.05% in Q3 2025, compared to 0.05% in Q2 2025 and 0.07% in Q1 2025.